In the News

Faculty Awards Honor Teaching, Clinical, Research excellence

The 2023 Vanderbilt University School of Medicine Faculty Awards for Excellence in Teaching, Extraordinary Performance of Clinical Service, and Outstanding Contributions to Research were presented May 19 during the annual spring faculty meeting. Dr. Xiao-Ou Shu received special recognition.

Dr. Andreana Holowatyj's GAP Study Is Making Headlines.

The Genetics of Appendix Cancer (GAP) Study is a research study of individuals with an appendix cancer diagnosis and their families. The goal of the GAP Study is to answer the question of: Is there a genetic link to appendix cancer? The GAP Study is a national crowdsourcing study of individuals who received an appendix cancer diagnosis between the ages of 18 and 99 years old.

Open Position: Postdoctoral Fellow in Multi-omics and Bioinformatics

We are seeking multiple enthusiastic and highly motivated postdoctoral fellows to join a multidisciplinary research team based in the Vanderbilt Epidemiology Center. Our group conducts multiple NIH-funded research projects, including four large population-based prospective cohort studies with more than 225,000 study participants. Our research focuses on discovering the environmental, lifestyle and genetic determinants of cancer and other chronic diseases.

Bots Boost Liver Cancer Outcome

Liver cancer, primarily hepatocellular carcinoma (HCC), is the third most common contributor to cancer-related deaths worldwide. Early-stage HCC has a better prognosis than advanced-stage HCC and can be treated with minimally invasive surgery, including robotic-assisted and laparoscopic options. However, few studies have examined the presumably unique and discrepant short-term and long-term outcomes of robotic-assisted and laparoscopic surgeries. Read more.

Blood test figures in cancer risk for people with HIV

In the clinical care of people living with HIV, various types of blood cells are routinely counted to assess the immune system, among them CD4+ cells, or T helper cells, and CD8+ cells, or cytotoxic T cells. These types of white blood cells work together to clear infections and prevent and kill cancer cells. While a normal CD4/CD8 ratio is about 2:1, it’s typically lower in people with HIV. Read more.